touchREVIEWS in Ophthalmology is a peer-reviewed, free-to-access, bi-annual journal that aims to provide insightful and topical articles relevant to the day-to-day practice of busy physicians.
The journal is of interest to physicians, healthcare professionals and researchers across Europe, USA, and ROW, providing practical advice relevant to the clinical setting on diagnosis and treatment within ophthalmology. touchREVIEWS in Ophthalmology endeavours to support these professionals in continuously developing their knowledge, effectiveness and productivity.
Editor-in-Chief: Elizabeth Yeu
Established: January 2007 Frequency: Bi-annual
Submit your article here.
Pharmacologic Mydriasis and Cycloplegia: A Review of Novel Delivery Devices
touchREVIEWS in Ophthalmology. 2023;17(2):1–3:Online ahead of journal publication
Mydriasis physiology Mydriasis refers to physiologic or pharmacologic pupillary dilation. Physiologic pupillary dilation occurs naturally as a response to low light and viewing objects in the distance. This process is mediated by both the iris sphincter and the iris dilator muscles, the latter of which contracts in response to sympathetic stimulation and relaxes in response to […]
Peering into the Dry Eye Pipeline for 2023 and Beyond
touchREVIEWS in Ophthalmology. 2023;17(2):1–4:Online ahead of journal publication
Dry eye disease (DED) is a multifactorial condition of the ocular surface and tears. It is frequently encountered in ocular practices, comprising nearly 33% of visits in the USA, and with an estimated global prevalence ranging between 5% and 50%.1,2 The chronic symptoms and discomfort reported by patients with DED directly impact their quality of life […]
Artificial Intelligence for the Diagnosis and Screening of Retinal Diseases
touchREVIEWS in Ophthalmology. 2023;17(2):Online ahead of journal publication
Article highlights Artificial intelligence (AI) represents a powerful way of analysing a large amount of data, extracting those features characterizing a given disease or condition. AI-based models have been largely tested in the main retinopathies, including age-related macular degeneration, diabetic retinopathy and myopia. AI algorithms have been highly effective in screening for retinopathies. The same […]
Foreword: touchREVIEWS in Ophthalmology, Volume 17, Issue 1, 2023
Welcome to the latest edition of touchREVIEWS in Ophthalmology. In this edition, we feature a range of reviews and editorials on various diseases, including glaucoma and ocular surface disease, to name but a few, discussing improvements in our understanding and novel treatment options for ophthalmological conditions. We begin this issue with an expert interview with […]
Neurotrophic Keratitis: Exploring the Therapeutic Landscape
touchREVIEWS in Ophthalmology. 2023;17(1):36–41 DOI: https://doi.org/10.17925/USOR.2023.17.1.36
The treatment options for neurotrophic keratitis (NK) are ever-evolving as the pathogenesis of this increasingly prevalent degenerative keratopathy is further elucidated. Currently available therapeutics can be divided into medical, procedural and surgical interventions that directly address the effects of corneal denervation as well as the comorbid conditions causing superimposed infection and inflammation in the affected […]
iDose TR Sustained-release Travoprost Implant for the Treatment of Glaucoma
touchREVIEWS in Ophthalmology. 2023;17(1):4–7 DOI: https://doi.org/10.17925/USOR.2023.17.1.4
The challenge of patient adherence Patient adherence is a major concern in the field of glaucoma, where medication adherence rates can be as low as 40–55% due to complex dosing regimens, unpleasant side effects and difficulty with eyedrop administration.1,2 Moreover, 25% of patients with glaucoma do not refill their second eyedrop prescription, making it challenging for […]
Submacular Choroidal Granuloma from Sarcoidosis: A Case Report
touchREVIEWS in Ophthalmology. 2023;17(1):42–4 DOI: https://doi.org/10.17925/USOR.2023.17.1.42
Choroidal granuloma is a relatively rare manifestation of sarcoidosis. Cases of sarcoid granuloma may lack accompanying ocular inflammation and can mimic posterior segment tumours, leading to a delay in diagnosis and treatment. These lesions are typically steroid responsive,1 and quick identification and treatment can result in improved visual outcomes.2 We report two cases of patients who presented […]
New and Emerging Trabecular Meshwork Bypass Stents
touchREVIEWS in Ophthalmology. 2023;1732(1):10–20 DOI: https://doi.org/10.17925/USOR.2023.17.1.10
Glaucoma is a major cause of irreversible blindness worldwide.1,2 High intraocular pressure (IOP) is one of the major risk factors for the development and progression of open-angle glaucoma (OAG) but is not an essential criterion for diagnosis.3,4 Nonetheless, lowering the IOP is considered the only proven intervention to decelerate disease progression.3–5 IOP can be reduced using topical hypotensive […]
High-dose Aflibercept with Increased Dosing Intervals as a New Standard of Care for DMO and nAMD
touchREVIEWS in Ophthalmology. 2023;17(1):8–9 DOI: https://doi.org/10.17925/USOR.2023.17.1.8
With the introduction of monoclonal antibody inhibitors for all isoforms of vascular endothelial growth factor (VEGF)-A, which were first presented in September 2005 with off-label use of bevacizumab, significant anatomical and visual improvements for neovascular age-related macular degeneration (nAMD) became a reality. Following the landmark ANCHOR and MARINA trials, which showed that monthly ranibizumab injections resulted in 7.2–11.0 Early Treatment Diabetic Retinopathy Study (ETDRS) letters gained after 1 year of treatment, anti-VEGF agents became the standard of care for nAMD.1,2 The […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!